The critical component in studying the pathophysiology and etiology of human disease is the requirement of a physiologically relevant experimental disease model that faithfully recapitulates the respective clinical manifestations and pathophysiology. The ground-breaking development of induced pluripotent stem cell (iPSC) technology provides investigators with a self-renewing and unlimited source of pluripotent cells for targeted differentiation and human disease modeling.